Search results for

Google Nose lets you sniff "15M+ sentibytes" via your computer screen. Twttr is for those who only want to use consonants. YouTube closes until 2023 because it has enough videos already. Morning Edition profiles "Hootie and the Time Travelers." The foolishness has begun.

Also: Chimamanda Ngozi Adichie disses V. S. Naipaul; a new biography of Derrida; and the best books coming out this week.

The once-every-17-years event begins when ground temperatures reach 64 degrees. This how-to will give you a heads up on the historic swarm.

Kevin Ware's injury may be the most talked-about story from the weekend's games, but there was other big news. On the women's side, Louisville shocked No. 1-ranked Baylor, knocking out the defending champions. On the men's side, Wichita State continues its surprising run.

Also: Texas officials are on high alert after prosecutor's death; drug maker Novartis loses a patent battle in India; Colorado prosecutors will say whether they plan to pursue death penalty in theater shootings.

MURFREESBORO, Tenn. (BURRISS) -- What do most Americans know about foreign cultures, and what kinds of pictures of foreign countries do we get from the…

Detroit's emergency management has a lot of parents and teachers worried about the city's public schools. The schools' manager is under fire for his controversial decisions like firing the interim superintendent. Guest host Celeste Headlee discusses the state of Detroit's schools with WDET's news director, Jerome Vaughn.

After years of gridlock, some observers say Congress could be close to a deal on new immigration policy. Guest host Celeste Headlee discusses this and other political news with Republican strategist Ron Christie and former adviser to the Obama administration, Corey Ealons.

James Holmes had offered to plead guilty in exchange for a life sentence. Prosecutors called that a publicity ploy. Twelve people died and another 58 were wounded in the attack.

Novartis lost its bid to patent one of its cancer drugs. Indian authorities say the drug is too much like an earlier version. Novartis says the ruling may dampen drug companies' willingness to work in India. Others say the ruling will help make less expensive drugs available to the world's poor.